Generali Investments Towarzystwo Funduszy Inwestycyjnych Gilead Sciences, Inc. Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $172 Billion
- Q4 2024
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 1,300 shares of GILD stock, worth $127,387. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,300
Previous 2,400
45.83%
Holding current value
$127,387
Previous $201 Million
40.32%
% of portfolio
0.07%
Previous 0.13%
Shares
6 transactions
Others Institutions Holding GILD
# of Institutions
1,968Shares Held
996MCall Options Held
10.5MPut Options Held
9.85M-
Black Rock Inc. New York, NY121MShares$11.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.3 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.5 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$6.06 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.9 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $123B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...